Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Diagnosing Pulmonary Aspergillosis in Patients With Hematological Malignancies: A Multicentre Prospective Evaluation of an Aspergillus PCR Assay and a Galactomannan ELISA in Bronchoalveolar Lavage Samples

NCT01430663 is registered in ClinicalTrials.gov with Heidelberg University as lead sponsor.

NCT NCT01430663
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01430663 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Diagnosing Pulmonary Aspergillosis in Patients With Hematological Malignancies: A Multicentre Prospective Evaluation of an Aspergillus PCR Assay and a Galactomannan ELISA in Bronchoalveolar Lavage Samples
Lead sponsor
Heidelberg University
Phase
Observational
Overall status
Completed
Start date
April 30, 2007
Completion date
February 28, 2011
Enrollment
87 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

invasive aspergillosis